Raynaud's phenomenon and digital ischaemia induced by ixekizumab

Rheumatology (Oxford). 2024 Jan 4;63(1):e3-e5. doi: 10.1093/rheumatology/kead270.

Authors

M Beatriz Paredes-Romero^{1

2}, Elisabet Castañeda-Estévez¹, Martina Steiner^{1

2}, Tatiana Cobo-Ibáñez^{1

2}, Ana Esteban-Vázquez¹, Santiago Muñoz-Fernández^{1

2}

Affiliations

¹ Rheumatology Department, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.
² Universidad Europea de Madrid, Madrid, Spain.

PMID: 37280057
DOI: 10.1093/rheumatology/kead270

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Humans
Ischemia / chemically induced
Raynaud Disease* / chemically induced

Substances

ixekizumab
Antibodies, Monoclonal, Humanized